EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Mediators of Endothelial Dysfunction

Eirini Dri, Evangelos Lampas, George Lazaros iD, Emilia Lazarou, Panagiotis Theofilis iD, Costas Tsioufis, Dimitris Tousoulis

Life · 20.06.2023 · 13 (6) · 1420

DOI: 10.3390/life13061420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 20.06.2023. Verfasst von Eirini Dri und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Cardiology, Hippokration General Hospital, Kapodistrian University of Athens Medical School, Vas. Sofias 114, 11528 Athens, Greece. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial dysfunction (ED) is characterized by imbalanced vasodilation and vasoconstriction, elevated reactive oxygen species (ROS), and inflammatory factors, as well as deficiency of nitric oxide (NO) bioavailability. It has been reported that the maintenance of endothelial cell integrity serves a significant role in human health and disease due to the involvement of the endothelium in several processes, such as regulation of vascular tone, regulation of hemostasis and thrombosis, cell adhesion, smooth muscle cell proliferation, and vascular inflammation. Inflammatory modulators/biomarkers, such as IL-1α, IL-1β, IL-6, IL-12, IL-15, IL-18, and tumor necrosis factor α, or alternative anti-inflammatory cytokine IL-10, and adhesion molecules (ICAM-1, VCAM-1), involved in atherosclerosis progression have been shown to predict cardiovascular diseases. Furthermore, several signaling pathways, such as NLRP3 inflammasome, that are associated with the inflammatory response and the disrupted H2S bioavailability are postulated to be new indicators for endothelial cell inflammation and its associated endothelial dysfunction. In this review, we summarize the knowledge of a plethora of reviews, research articles, and clinical trials concerning the key inflammatory modulators and signaling pathways in atherosclerosis due to endothelial dysfunction.

Schlagwörter

Stichwörter der Autor:innen

H2S gasotransmitterNLRP3 inflammasomeatherosclerosisendothelial dysfunctioninflammatory modulators

Autor:innen und Institutionen

  • 1st Department of Cardiology, Hippokration General Hospital, Kapodistrian University of Athens Medical School, Vas. Sofias 114, 11528 Athens, Greece.
  • Department of Cardiology, Konstantopouleio General Hospital, 14233 Athens, Greece.

ORCID-Profile: George Lazaros, Panagiotis Theofilis

Zitieren

APA

Dri, E., Lampas, E., Lazaros, G., Lazarou, E., Theofilis, P., Tsioufis, C., & Tousoulis, D. (2023). Inflammatory Mediators of Endothelial Dysfunction. Life, 13(6), 1420. https://doi.org/10.3390/life13061420

Vancouver

Dri E, Lampas E, Lazaros G, Lazarou E, Theofilis P, Tsioufis C, et al. Inflammatory Mediators of Endothelial Dysfunction. Life. 2023;13(6):1420. doi:10.3390/life13061420

BibTeX
@article{Dri2023,
  author = {Dri, Eirini and Lampas, Evangelos and Lazaros, George and Lazarou, Emilia and Theofilis, Panagiotis and Tsioufis, Costas and Tousoulis, Dimitris},
  title = {Inflammatory Mediators of Endothelial Dysfunction},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {6},
  pages = {1420},
  doi = {10.3390/life13061420}
}
Kostenlos starten →